Ultragenyx Pharmaceutical Inc. buy Barclays PLC
Start price
29.04.26
/
50%
€20.71
Target price
29.04.27
€36.72
Performance (%)
-8.18%
Price
05.06.26
€18.85
Summary
This prediction is currently active. With a performance of -8.18%, the BUY prediction by Barclays_PLC is trending in the wrong direction. This prediction currently runs until 29.04.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -7.371% | -7.371% |
| iShares Core DAX® | -1.862% | -1.624% |
| iShares Nasdaq 100 | -3.322% | 3.321% |
| iShares Nikkei 225® | -2.299% | 3.437% |
| iShares S&P 500 | -1.313% | 2.435% |
Comments by Barclays_PLC for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (RARE) had its price target lowered by Barclays PLC from $44.00 to $43.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Barclays_PLC for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€28.40
24.11.25
24.11.25
€43.44
24.11.26
24.11.26
-33.05%
05.06.26
05.06.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€45.20
06.08.24
06.08.24
€74.24
06.08.25
06.08.25
-48.67%
07.08.25
07.08.25